Relistore Dosing Information
I cannot provide specific dosing recommendations for "Relistore" as this product does not appear in any of the provided medical evidence, guidelines, or drug labels.
Critical Clarification Needed
The evidence provided contains no information about a product called "Relistore." The search results include:
- Faecal microbiota transplant (FMT) guidelines for Clostridium difficile infection 1
- RELiZORB, an in-line digestive cartridge for enteral nutrition in cystic fibrosis 2
- Relcer, an antacid medication for GERD and ulcer disease 3
- Various other gastrointestinal treatments including rifaximin, alosetron, and loperamide 1
If You Are Referring to a Microbiome Therapeutic
For FMT Products (if this is what you meant):
Capsulized FMT dosing for recurrent C. difficile infection:
- 40 capsules administered as a single treatment achieved 96% remission at 12 weeks, equivalent to colonoscopic delivery 1
- Alternative "high dose" regimen: 30 capsules daily for 2 consecutive days (total 60 capsules) achieved 77% resolution 1
- Alternative "low dose" regimen: 30 capsules in a single day achieved 70% resolution 1
- 15 capsules daily for 2 consecutive days (total 30 capsules) achieved 82% resolution after one course and 91% after two courses 1
For RELiZORB (if this is what you meant):
RELiZORB is used with overnight enteral nutrition in patients with cystic fibrosis and pancreatic insufficiency to hydrolyze fat in enteral formula 2. It is an in-line digestive cartridge, not an oral medication with standard dosing.
Next Steps
Please clarify the exact product name or provide additional context about:
- The specific indication (recurrent CDI, IBS-D, other GI condition)
- Whether this is a capsulized FMT product, probiotic, or other microbiome therapeutic
- The manufacturer or FDA approval status
Without accurate product identification, providing dosing recommendations would be unsafe and potentially harmful to patient care.